{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:23:42Z","timestamp":1789813422668,"version":"4.0.1"},"reference-count":41,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2026-0062_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Gout is a metabolic disorder characterized by hyperuricemia and urate crystal deposition. This study evaluated the xanthine oxidase inhibitory, antihyperuricemic, anti-inflammatory, analgesic, and\n                      <jats:italic>in silico<\/jats:italic>\n                      target-binding properties of an EtOAc fraction of\n                      <jats:italic>Piper betle<\/jats:italic>\n                      L. aerial\u00a0parts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2026-0062_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>P.\u00a0betle<\/jats:italic>\n                      aerial parts were extracted with ethanol and partitioned to obtain an EtOAc fraction. Xanthine oxidase inhibition was evaluated spectrophotometrically, and antihyperuricemic activity was examined in potassium oxonate-treated mice given the fraction (200 or 600\u202fmg\/kg). Carrageenan-induced paw edema and acetic acid-induced writhing were used to assess anti-inflammatory and analgesic effects. Hydroxychavicol was docked with xanthine oxidase, cyclooxygenase-2, and transient receptor potential vanilloid 1, followed by molecular dynamics simulations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2026-0062_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The ethyl acetate fraction inhibited xanthine oxidase with an IC\n                      <jats:sub>50<\/jats:sub>\n                      of 4.28\u00a0\u00b1\u00a00.15\u202f\u03bcg\/mL, whereas allopurinol showed an IC\n                      <jats:sub>50<\/jats:sub>\n                      of 1.06\u00a0\u00b1\u00a00.07\u202f\u03bcg\/mL. In hyperuricemic mice, serum uric acid showed a decreasing trend, and urinary uric acid was significantly reduced at 600\u202fmg\/kg. Paw edema was reduced at 600\u202fmg\/kg, whereas writhing responses were not significantly inhibited. Docking predicted favorable hydroxychavicol binding to the three targets, but molecular dynamics indicated weaker ligand retention in the xanthine oxidase complex than in the cyclooxygenase-2 and transient receptor potential vanilloid 1 complexes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2026-0062_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The ethyl acetate fraction of\n                      <jats:italic>P.\u00a0betle<\/jats:italic>\n                      demonstrated preclinical xanthine oxidase inhibitory, urate-lowering, and anti-inflammatory potential. Stronger chemical standardization and mechanistic validation are required before therapeutic relevance can be inferred.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2026-0062","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:56:40Z","timestamp":1789811800000},"source":"Crossref","is-referenced-by-count":0,"title":["<i>In vitro, in\u00a0vivo<\/i>\n                    , and computational evaluation of xanthine oxidase inhibitory and antihyperuricemic activities of\n                    <i>Piper betle<\/i>\n                    L. ethyl acetate fraction"],"prefix":"10.1515","author":[{"given":"Bui Thi","family":"Hao","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Vietnam University of Traditional Medicine , Hanoi , Vietnam"},{"name":"National Institute of Medicinal Materials , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Hong","family":"Minh","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, VNU University of Medicine and Pharmacy, Vietnam National University Hanoi , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Anh Hong","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, VNU University of Medicine and Pharmacy, Vietnam National University Hanoi , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Nam","family":"Nhat","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, VNU University of Medicine and Pharmacy, Vietnam National University Hanoi , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Minh","family":"Khoi","sequence":"additional","affiliation":[{"name":"National Institute of Medicinal Materials , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bui Thanh","family":"Tung","sequence":"additional","affiliation":[{"name":"Academy of Security Engineering and Technology , Bac Ninh , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026091909563377002_j_jcim-2026-0062_ref_001","doi-asserted-by":"crossref","unstructured":"Jin, S, Wang, Y, Yan, S, Fu, X, Hu, X, Lyu, Z, et al.. Global burden and trends of gout incidence and prevalence. Chin Med J 2025;138:3153\u201362. https:\/\/doi.org\/10.1097\/cm9.0000000000003631.","DOI":"10.1097\/CM9.0000000000003631"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_002","doi-asserted-by":"crossref","unstructured":"Han, T, Chen, W, Qiu, X, Wang, W. Epidemiology of gout\u2013global burden of disease research from 1990 to 2019 and future trend predictions. Ther Adv Endocrinol Metab 2024;15:20420188241227295. https:\/\/doi.org\/10.1177\/20420188241227295.","DOI":"10.1177\/20420188241227295"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_003","doi-asserted-by":"crossref","unstructured":"Dalbeth, N, Gosling, AL, Gaffo, A, Abhishek, A. Gout Lancet 2021;397:1843\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(21)00569-9.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_004","doi-asserted-by":"crossref","unstructured":"Dalbeth, N, Merriman, TR, Stamp, LK. Gout Lancet 2016;388:2039\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(16)00346-9.","DOI":"10.1016\/S0140-6736(16)00346-9"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_005","doi-asserted-by":"crossref","unstructured":"Piancone, F, Saresella, M, Marventano, I, La Rosa, F, Santangelo, MA, Caputo, D, et al.. Monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis. Front Immunol 2018;9:983. https:\/\/doi.org\/10.3389\/fimmu.2018.00983.","DOI":"10.3389\/fimmu.2018.00983"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_006","doi-asserted-by":"crossref","unstructured":"Singh, C, Jain, S, Dhawan, V, Kalra, N, Kumari, S. Uric acid as a predictor of endothelial dysfunction in patients with metabolic syndrome. Arch Endocrinol Metab 2020;64:810\u20135.","DOI":"10.20945\/2359-3997000000298"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_007","doi-asserted-by":"crossref","unstructured":"Zuo, T, Liu, X, Jiang, L, Mao, S, Yin, X, Guo, L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord 2016;16:207. https:\/\/doi.org\/10.1186\/s12872-016-0379-z.","DOI":"10.1186\/s12872-016-0379-z"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_008","doi-asserted-by":"crossref","unstructured":"Jung, SW, Kim, S-M, Kim, YG, Lee, S-H, Moon, J-Y. Uric acid and inflammation in kidney disease. Am J Physiol Ren Physiol 2020;318:F1327\u201340.","DOI":"10.1152\/ajprenal.00272.2019"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_009","doi-asserted-by":"crossref","unstructured":"Leggatt, GP, Seaby, EG, Veighey, K, Gast, C, Gilbert, RD, Ennis, S. A role for genetic modifiers in tubulointerstitial kidney diseases. Genes 2023;14:1582. https:\/\/doi.org\/10.3390\/genes14081582.","DOI":"10.3390\/genes14081582"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_010","doi-asserted-by":"crossref","unstructured":"Richette, P, Bardin, T. Gout Lancet 2010;375:318\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(09)60883-7.","DOI":"10.1016\/S0140-6736(09)60883-7"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_011","doi-asserted-by":"crossref","unstructured":"Nuki, G, Doherty, M, Richette, P. Current management of gout: practical messages from 2016 EULAR guidelines. Pol Arch Intern Med 2017;127:267\u201377. https:\/\/doi.org\/10.20452\/pamw.4001.","DOI":"10.20452\/pamw.4001"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_012","doi-asserted-by":"crossref","unstructured":"Ramasamy, SN, Korb-Wells, CS, Kannangara, DR, Smith, MW, Wang, N, Roberts, DM, et al.. Allopurinol hypersensitivity: a systematic review of all published cases, 1950\u20132012. Drug Saf 2013;36:953\u201380. https:\/\/doi.org\/10.1007\/s40264-013-0084-0.","DOI":"10.1007\/s40264-013-0084-0"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_013","doi-asserted-by":"crossref","unstructured":"Abeles, AM, Pillinger, MH. Febuxostat and the black box blues. ACR Open Rheumatol 2019;1:343. https:\/\/doi.org\/10.1002\/acr2.11047.","DOI":"10.1002\/acr2.11047"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_014","doi-asserted-by":"crossref","unstructured":"Haber, SL, Fente, G, Fenton, SN, Walker, EP, Weaver, BM, Cano, AJ, et al.. Lesinurad: a novel agent for management of chronic gout. Ann Pharmacother 2018;52:690\u20136. https:\/\/doi.org\/10.1177\/1060028018762103.","DOI":"10.1177\/1060028018762103"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_015","doi-asserted-by":"crossref","unstructured":"Wilson, L, Saseen, JJ. Gouty arthritis: a review of acute management and prevention. Pharmacotherapy. J\u00a0Hum Pharmacol Drug Ther 2016;36:906\u201322. https:\/\/doi.org\/10.1002\/phar.1788.","DOI":"10.1002\/phar.1788"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_016","doi-asserted-by":"crossref","unstructured":"Riaz, M, Rasool, G, Yousaf, R, Fatima, H, Munir, N, Ejaz, H. Anti-rheumatic potential of biological DMARDS and protagonistic role of bio-markers in early detection and management of rheumatoid arthritis. Innate Immun 2025;31:17534259251324820. https:\/\/doi.org\/10.1177\/17534259251324820.","DOI":"10.1177\/17534259251324820"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_017","doi-asserted-by":"crossref","unstructured":"Agarwal, A, Banerjee, A, Banerjee, U. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling. Crit Rev Biotechnol 2011;31:264\u201380. https:\/\/doi.org\/10.3109\/07388551.2010.527823.","DOI":"10.3109\/07388551.2010.527823"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_018","doi-asserted-by":"crossref","unstructured":"Kanczler, JM, Millar, TM, Bodamyali, T, Blake, DR, Stevens, CR. Xanthine oxidase mediates cytokine-induced, but not hormone-induced bone resorption. Free Radic Res 2003;37:179\u201387. https:\/\/doi.org\/10.1080\/1071576021000040673.","DOI":"10.1080\/1071576021000040673"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_019","doi-asserted-by":"crossref","unstructured":"Seo, J, Lee, U, Seo, S, Wibowo, AE, Pongtuluran, OB, Lee, K, et al.. Anti-inflammatory and antioxidant activities of methanol extract of Piper betle Linn. (Piper betle L.) leaves and stems by inhibiting NF-kappaB\/MAPK\/Nrf2 signaling pathways in RAW 264.7 macrophages. Biomed Pharmacother 2022;155:113734. https:\/\/doi.org\/10.1016\/j.biopha.2022.113734.","DOI":"10.1016\/j.biopha.2022.113734"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_020","doi-asserted-by":"crossref","unstructured":"Abu-Gharbieh, E, Shehab, NG, Almasri, IM, Bustanji, Y. Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: in\u00a0vitro and in\u00a0vivo investigation and docking simulations. PLoS One 2018;13:e0202572. https:\/\/doi.org\/10.1371\/journal.pone.0202572.","DOI":"10.1371\/journal.pone.0202572"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_021","doi-asserted-by":"crossref","unstructured":"Sun, ZG, Wu, KX, Ullah, I, Zhu, HL. Recent advances in xanthine oxidase inhibitors. Mini Rev Med Chem 2024;24:1177\u201386. https:\/\/doi.org\/10.2174\/1389557523666230913091558.","DOI":"10.2174\/1389557523666230913091558"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_022","doi-asserted-by":"crossref","unstructured":"Mehmood, A, Ishaq, M, Zhao, L, Safdar, B, Rehman, A, Munir, M, et al.. Natural compounds with xanthine oxidase inhibitory activity: a review. Chem Biol Drug Des 2019;93:387\u2013418. https:\/\/doi.org\/10.1111\/cbdd.13437.","DOI":"10.1111\/cbdd.13437"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_023","doi-asserted-by":"crossref","unstructured":"Ho, TT, Tran, QT, Chai, CL. The polypharmacology of natural products. Future Med Chem 2018;10:1361\u20138. https:\/\/doi.org\/10.4155\/fmc-2017-0294.","DOI":"10.4155\/fmc-2017-0294"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_024","doi-asserted-by":"crossref","unstructured":"Biswas, P, Anand, U, Saha, SC, Kant, N, Mishra, T, Masih, H, et al.. Betelvine (Piper betle L.): a comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes. J\u00a0Cell Mol Med 2022;26:3083\u2013119. https:\/\/doi.org\/10.1111\/jcmm.17323.","DOI":"10.1111\/jcmm.17323"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_025","unstructured":"Shah, SK, Garg, G, Jhade, D, Patel, N. Piper betle: phytochemical, pharmacological and nutritional value in health management. Int J Pharmaceut Sci Rev Res 2016;38:181\u20139."},{"key":"2026091909563377002_j_jcim-2026-0062_ref_026","doi-asserted-by":"crossref","unstructured":"Ramji, N, Ramji, N, Iyer, R, Chandrasekaran, S. Phenolic antibacterials from Piper betle in the prevention of halitosis. J\u00a0Ethnopharmacol 2002;83:149\u201352. https:\/\/doi.org\/10.1016\/s0378-8741(02)00194-0.","DOI":"10.1016\/S0378-8741(02)00194-0"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_027","unstructured":"Thanh, NPT, Pham, PD, Hoang, DM, Kim, M-TN, Tran, TT. Extracting hydroxychavicol and evaluating the antibacterial and antifungal properties of betel leaf extract (Piper betle L.). Chem Eng Trans 2024;113:343\u20138."},{"key":"2026091909563377002_j_jcim-2026-0062_ref_028","doi-asserted-by":"crossref","unstructured":"Herrera-Pool, E, Ramos-Diaz, AL, Lizardi-Jimenez, MA, Pech-Cohuo, S, Ayora-Talavera, T, Cuevas-Bernardino, JC, et al.. Effect of solvent polarity on the ultrasound assisted extraction and antioxidant activity of phenolic compounds from habanero pepper leaves (Capsicum chinense) and its identification by UPLC-PDA-ESI-MS\/MS. Ultrason Sonochem 2021;76:105658. https:\/\/doi.org\/10.1016\/j.ultsonch.2021.105658.","DOI":"10.1016\/j.ultsonch.2021.105658"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_029","doi-asserted-by":"crossref","unstructured":"Amir, S, Abid, M, Nadeem, H, Tipu, MK, Irshad, N. The nephroprotective potential of selected synthetic compound against gentamicin induced nephrotoxicity. BMC Pharmacol Toxicol 2024;25:68. https:\/\/doi.org\/10.1186\/s40360-024-00765-3.","DOI":"10.1186\/s40360-024-00765-3"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_030","doi-asserted-by":"crossref","unstructured":"Rathee, JS, Patro, BS, Mula, S, Gamre, S, Chattopadhyay, S. Antioxidant activity of piper betel leaf extract and its constituents. J\u00a0Agric Food Chem 2006;54:9046\u201354. https:\/\/doi.org\/10.1021\/jf061679e.","DOI":"10.1021\/jf061679e"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_031","doi-asserted-by":"crossref","unstructured":"Ou, J, Zhong, F, Huang, P, Zhang, Y, Xie, S, Wu, P, et al.. Hydroxychavicol derivatives from Piper betle Linn. as natural PDE4 inhibitors with anti-inflammatory effects. Bioorg Chem 2025;157:108294. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108294.","DOI":"10.1016\/j.bioorg.2025.108294"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_032","unstructured":"Bui, TT, Duong, TKD, Bui, SN. Evaluating the antioxidant and xanthine oxidase enzyme inhibitory activities in\u00a0vitro of Piper betle Linn. Leaf Extr VNU J Sci Medi Pharm Sci 2020;36."},{"key":"2026091909563377002_j_jcim-2026-0062_ref_033","doi-asserted-by":"crossref","unstructured":"Chang, MC, Uang, BJ, Tsai, CY, Wu, HL, Lin, BR, Lee, CS, et al.. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Br J Pharmacol 2007;152:73\u201382. https:\/\/doi.org\/10.1038\/sj.bjp.0707367.","DOI":"10.1038\/sj.bjp.0707367"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_034","doi-asserted-by":"crossref","unstructured":"Endrini, S, Bakar, FIA, Bakar, MFA, Abdullah, N, Marsiati, H. Phytochemical profiling, in\u00a0vitro and in\u00a0vivo xanthine oxidase inhibition and antihyperuricemic activity of Christia vespertilionis leaf. Biocatal Agric Biotechnol 2023;48:102645. https:\/\/doi.org\/10.1016\/j.bcab.2023.102645.","DOI":"10.1016\/j.bcab.2023.102645"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_035","doi-asserted-by":"crossref","unstructured":"Gundala, SR, Yang, C, Mukkavilli, R, Paranjpe, R, Brahmbhatt, M, Pannu, V, et al.. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharmacol 2014;280:86\u201396. https:\/\/doi.org\/10.1016\/j.taap.2014.07.012.","DOI":"10.1016\/j.taap.2014.07.012"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_036","doi-asserted-by":"crossref","unstructured":"Gupta, AK, Parasar, D, Sagar, A, Choudhary, V, Chopra, BS, Garg, R, et al.. Analgesic and anti-inflammatory properties of gelsolin in acetic acid induced writhing, tail immersion and carrageenan induced paw edema in mice. PLoS One 2015;10:e0135558. https:\/\/doi.org\/10.1371\/journal.pone.0135558.","DOI":"10.1371\/journal.pone.0135558"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_037","doi-asserted-by":"crossref","unstructured":"Morris, CJ. Carrageenan-induced paw edema in the rat and mouse. Inflammation Protoc 2003;225:115\u201321.","DOI":"10.1385\/1-59259-374-7:115"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_038","unstructured":"Alam, B, Akter, F, Parvin, N, Sharmin Pia, R, Akter, S, Chowdhury, J, et al.. Antioxidant, analgesic and anti-inflammatory activities of the methanolic extract of Piper betle leaves. Avicenna J Phytomed 2013;3:112\u201325."},{"key":"2026091909563377002_j_jcim-2026-0062_ref_039","doi-asserted-by":"crossref","unstructured":"Vijeesh, V, Jisha, N, Vysakh, A, Latha, MS. Interaction of eugenol with xanthine oxidase: multi spectroscopic and in\u00a0silico modelling approach. Spectrochim Acta Mol Biomol Spectrosc 2021;258:119843. https:\/\/doi.org\/10.1016\/j.saa.2021.119843.","DOI":"10.1016\/j.saa.2021.119843"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_040","doi-asserted-by":"crossref","unstructured":"Nishiwaki, K, Ohigashi, K, Deguchi, T, Murata, K, Nakamura, S, Matsuda, H, et al.. Structure-activity relationships and docking studies of hydroxychavicol and its analogs as xanthine oxidase inhibitors. Chem Pharm Bull (Tokyo) 2018;66:741\u20137. https:\/\/doi.org\/10.1248\/cpb.c18-00197.","DOI":"10.1248\/cpb.c18-00197"},{"key":"2026091909563377002_j_jcim-2026-0062_ref_041","doi-asserted-by":"crossref","unstructured":"Murata, K, Nakao, K, Hirata, N, Namba, K, Nomi, T, Kitamura, Y, et al.. Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle. J\u00a0Nat Med 2009;63:355\u20139. https:\/\/doi.org\/10.1007\/s11418-009-0331-y.","DOI":"10.1007\/s11418-009-0331-y"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2026-0062\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2026-0062\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:56:58Z","timestamp":1789811818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2026-0062\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":41,"alternative-id":["10.1515\/jcim-2026-0062"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2026-0062","relation":{},"ISSN":["2194-6329","1553-3840"],"issn-type":[{"value":"2194-6329","type":"print"},{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}